Patents by Inventor Kirk A. Staschke

Kirk A. Staschke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for identifying anti-HCV agents
    Patent number: 7655419
    Abstract: The invention features methods and compositions for screening for agents that modulate replication of a virus, particularly Flaviviridae virus (particularly hepatitis C virus (HCV)), where the methods provide for detection of agents that modulate the binding of TBC and NS5A, the inhibition of TBC activity, inhibition of Rab1 activity, and/or the expression of the TBC protein and/or Rab1 protein. The invention also features methods of controlling viral replication, and agents useful in such methods.
    Type: Grant
    Filed: August 24, 2007
    Date of Patent: February 2, 2010
    Assignees: The Board of Trustees of the Leland Stanford Junior University, Eli Lily and Company
    Inventors: Jeffrey Glenn, Ella Sklan, Kirk A. Staschke, Tina Myers Oakes
  • METHODS AND COMPOSITIONS FOR IDENTIFYING ANTI-HCV AGENTS
    Publication number: 20080261906
    Abstract: The invention features methods and compositions for screening for agents that modulate replication of a virus, particularly Flaviviridae virus (particularly hepatitis C virus (HCV)), where the methods provide for detection of agents that modulate the binding of TBC and NS5A, the inhibition of TBC activity, inhibition of Rab1 activity, and/or the expression of the TBC protein and/or Rab1 protein. The invention also features methods of controlling viral replication, and agents useful in such methods.
    Type: Application
    Filed: August 24, 2007
    Publication date: October 23, 2008
    Inventors: Jeffrey Glenn, Ella Sklan, Kirk Staschke, Tina Myers Oakes